
Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
Author(s) -
Yining Dai,
Chengfu Xu,
Hongying Pan,
Haijun Huang,
Mei-Juan Chen,
Youming Li,
Chaohui Yu
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i13.4097
Subject(s) - steatosis , medicine , nonalcoholic fatty liver disease , fatty liver , gastroenterology , liver function tests , steatohepatitis , liver biopsy , liver function , alanine aminotransferase , disease , biopsy
Recently, nonalcoholic fatty liver disease (NAFLD) has been renamed metabolic-associated fatty liver disease (MAFLD). Based on the definition for MAFLD, a group of non-obese and metabolically healthy individuals with fatty liver are excluded from the newly proposed nomenclature.